MOR Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
1,738
-129
-7% -$132K 0.83% 22
2026
Q1
$1.72M Sell
1,867
-6
-0.3% -$6.08K 0.79% 25
2025
Q4
$2.01M Buy
+1,873
New +$1.79M 0.92% 22

Other funds holding LLY

MOR Wealth Management's LLY Position: Q2 2026 in Review

MOR Wealth Management reduced its Eli Lilly (LLY) stake by 6.9% in Q2 2026, selling an estimated $132K and leaving 1,738 shares worth $2.08M. The position accounts for 0.83% of the portfolio, ranked #22.

MOR Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MOR Wealth Management held 1,738 shares of Eli Lilly worth $2.08M as of Q2 2026.
  • MOR Wealth Management sold 129 Eli Lilly shares in Q2 2026, an estimated $132K.
  • Eli Lilly made up 0.83% of MOR Wealth Management's portfolio in Q2 2026, its #22 holding.
  • MOR Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MOR Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.